Financial News
Headline News about Havn Life Sciences Inc
![](https://cdn.benzinga.com/files/images/story/2024/07/31/image006.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/08/19/verne-ho-0lajfsna-xq-unsplash.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/08/01/psychedelics_earnings_2.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/06/28/psychedelics_ma_pexels.jpg?width=1200&height=800&fit=crop)
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/psyched_cover_ver_2_15.jpg?width=720)
![](https://cdn.benzinga.com/files/images/story/2012/deal_9.jpg?width=1200&height=800&fit=crop)
HAVN Life Enters Distribution Agreement With Mycrodose Therapeutics For U.S. Market
February 10, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/mari-liis-link-cwu4agioqay-unsplash1.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/maarten-van-den-heuvel-siuwr3ucir0-unsplash.jpg)
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/greg_engels.jpg?width=720)
Former Tilray CEO Joins Psychedelics Company
October 07, 2021
Via Benzinga
Topics
Cannabis
Exposures
Cannabis
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/psyched_cover_ver_2_3.jpg?width=720)
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/psyched_cover_ver_2_6.jpg?width=720)
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/psyched_cover_ver_2_1.jpg?width=720)
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/psyched_cover_ver_2.jpg?width=720)
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/pexels-anna-nekrashevich-6801874_4.jpg?width=720)
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/psyched_cover-01_41.jpg?width=720)
![](https://talkmarkets.com/contributor/mirjana-mishevska/user_content/ckimages/orig_psc_637614475459891128.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/mushrooms_image.png)
![](https://talkmarkets.com/contributor/mirjana-mishevska/user_content/ckimages/brain-4866447_640_637502416580905201.png)
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/psyched_cover-01_34.jpg?width=720)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.